27.07.2013 00:05:00

Ryan & Maniskas, LLP Announces Investigation of USANA Health Sciences Inc.

WAYNE, Pa., July 26, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/usna) announces that it is investigating potential claims against USANA Health Sciences Inc. ("USANA Health" or the "Company") (NYSE: USNA) on behalf of those who purchased USANA common stock between October 23, 2012 and July 23, 2013 (the "Class Period").

(Logo: http://photos.prnewswire.com/prnh/20121112/MM11729LOGO )

The investigation concerns whether USANA Health and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On July 23, 2013, USANA Health announced that the Securities and Exchange Commission (SEC), is conducting an investigation, which appears to involve possible issues regarding trading in the Company's stock during 2012 by certain of the Company's officers and directors including the Company's Chairman.  On this news, the shares of USANA Health fell $6.56, or 8.14% percent, to $73.99 on July 24, 2013.

For more information regarding this, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at rmaniskas@rmclasslaw.com or visit: www.rmclasslaw.com/cases/che. For more information about class action cases in general or to learn more about Ryan & Maniskas, LLP, please visit our website: www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm.  Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

CONTACT:                Ryan & Maniskas, LLP 
                                 Richard A. Maniskas, Esquire 
                                 995 Old Eagle School Rd., Suite 311 
                                 Wayne, PA 19087 
                                 484-588-5516 
                                 877-316-3218 
                                 www.rmclasslaw.com/cases/usna  
                                 rmaniskas@rmclasslaw.com

SOURCE Ryan & Maniskas, LLP

Analysen zu USANA Health Sciences Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

USANA Health Sciences Inc. 36,40 -0,55% USANA Health Sciences Inc.